Kenneth M. Murphy, MD, PhD, recognized with the 2026 AACR-CRI Lloyd J. Old Award in Cancer Immunology
Grant and Award Announcement
Updates every hour. Last Updated: 22-Jun-2026 04:16 ET (22-Jun-2026 08:16 GMT/UTC)
The organoids make it possible to observe the disease in a slightly more realistic environment, compared to single-layer cell cultures, and to improve drug screening before carrying out clinical trials with patients. The group of researchers has therefore developed organoids from pluripotent stem cells and used them to develop the tumor.
Novel blood-based biomarker predicts cancer risk in patients with Lynch Syndrome
New epigenetic target sensitizes pancreatic tumors to immunotherapy
Promising strategy may help to overcome radiotherapy resistance in lung cancer
High dose radiation therapy improves outcomes for patients with bile duct tumors
Recently, the Insilico team’s research entitled “An Internal Sulfur-Lone Pair Interaction Enabled the Discovery of Potential and Sub-Family Selective PKMYT1 Inhibitors” was invited for publication as a cover Feature in ChemMedChem[1].
NCCN announces the selection of Nancy L. Lewis, MD, MBS, FACP, as new Chief Scientific Officer (CSO).